Tonix Pharmaceuticals Holding Corp (TNXP)
SG&A Expenses
$35.96M
Quarterly · Period ending: · USD
TNXP SG&A Expenses
Latest reported$35.96Mperiod ending
Latest reported$35.96Mperiod ending
TNXP Quarterly SG&A Expenses ($45.00 → $35.96M)
Quarterly SG&A Expenses
High-resolution chart · PNG
TNXP sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 35,959,000 | |
| 28,069,000 | |
| 35,189,000 | |
| 0 | |
| 0 | |
| 10,104,000 | |
| 15,582,000 | |
| 0 | |
| 7,502,000 | |
| 9,310,000 | |
| 10,130,000 | |
| 8,712,000 | |
| 7,026,000 | |
| 7,391,000 | |
| 8,054,000 | |
| 7,390,000 | |
| 6,757,000 | |
| 8,014,000 | |
| 7,183,000 | |
| 5,453,000 | |
| 5,429,000 | |
| 5,409,000 | |
| 4,926,000 | |
| 3,186,000 | |
| 3,621,000 | |
| 2,621,000 | |
| 3,044,000 | |
| 2,839,000 | |
| 2,352,000 | |
| 2,401,000 | |
| 2,593,000 | |
| 2,277,000 | |
| 2,076,000 | |
| 1,818,000 | |
| 1,909,000 | |
| 1,927,000 | |
| 2,016,000 | |
| 2,097,000 | |
| 2,631,000 | |
| 2,143,000 | |
| 2,320,000 | |
| 3,343,000 | |
| 3,912,000 | |
| 2,966,000 | |
| 2,913,000 | |
| 2,867,000 | |
| 3,229,000 | |
| 2,217,000 | |
| 1,974,000 | |
| 1,619,000 | |
| 2,382,000 | |
| 1,454,853 | |
| 1,141,694 | |
| 1,260,596 | |
| 1,216,016 | |
| 1,076,199 | |
| 1,023,150 | |
| 762,737 | |
| 2,211,008 | |
| 2,322 | |
| 1,516 | |
| 5,515 | |
| 1,815 | |
| 3,685 | |
| 2,402 | |
| 5,822 | |
| 3,482 | |
| 2,613 | |
| 5,408 | |
| 2,364 | |
| 8,977 | |
| 2,412 | |
| 2,589 | |
| 45 |